Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis.
Pesqué D, Borrego L, Zaragoza-Ninet V, Sanz-Sánchez T, Miquel-Miquel FJ, González-Pérez R, Silvestre JF, Córdoba-Guijarro S, Carrascosa JM, Gatica-Ortega ME, Ruiz-González I, Mercader-García P, Tous-Romero F, Ortiz de Frutos FJ, Serra-Baldrich E, Pastor-Nieto MA, Rodríguez-Serna M, Sánchez-Pérez J, Sánchez-Gilo A, Melé-Ninot G, Sánchez-Pedreño Guillén P, Pujol RM, Giménez-Arnau AM. Pesqué D, et al. Among authors: carrascosa jm. J Eur Acad Dermatol Venereol. 2024 Feb 27. doi: 10.1111/jdv.19934. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38411353
Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry.
Carrascosa JM, Vilavella M, Garcia-Doval I, Carretero G, Vanaclocha F, Daudén E, Gómez-García FJ, Herrera-Ceballos E, De la Cueva Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferrán M, Peral F, Torrado R, Rivera R, Jiménez-Puya R, Mendiola MV, Ferrándiz C; BIOBADADERM Study Group. Carrascosa JM, et al. J Eur Acad Dermatol Venereol. 2014 Jul;28(7):907-14. doi: 10.1111/jdv.12208. Epub 2013 Jul 15. J Eur Acad Dermatol Venereol. 2014. PMID: 23848131
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry.
Carretero G, Ferrandiz C, Dauden E, Vanaclocha Sebastián F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina-Gibert M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Carazo C, Rivera R, Jiménez-Puya R, García-Doval I; BIOBADADERM Study Group. Carretero G, et al. Among authors: carrascosa jm. J Eur Acad Dermatol Venereol. 2015 Jan;29(1):156-63. doi: 10.1111/jdv.12492. Epub 2014 Mar 31. J Eur Acad Dermatol Venereol. 2015. PMID: 24684267
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.
Medina C, Carretero G, Ferrandiz C, Dauden E, Vanaclocha F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferrán M, Carrascosa JM, Torrado R, Argila D, Rivera R, Jiménez-Puya R, García-Doval I; BIOBADADERM Study Group. Medina C, et al. Among authors: carrascosa jm. J Eur Acad Dermatol Venereol. 2015 May;29(5):858-64. doi: 10.1111/jdv.12688. Epub 2014 Sep 3. J Eur Acad Dermatol Venereol. 2015. PMID: 25185962
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.
Pérez-Plaza A, Carretero G, Ferrandiz C, Vanaclocha F, Gómez-García FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchón I, Sánchez-Carazo JL, Alsina M, López-Estebaranz JL, Ferrán M, Torrado R, Carrascosa JM, Llamas-Velasco M, Rivera R, Jiménez-Puya R, García-Doval I, Descalzo MA; Biobadaderm Study Group. Pérez-Plaza A, et al. Among authors: carrascosa jm. J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1021-1028. doi: 10.1111/jdv.14188. Epub 2017 Apr 12. J Eur Acad Dermatol Venereol. 2017. PMID: 28252811
Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm.
Belinchón I, Ramos JM, Carretero G, Ferrándiz C, Rivera R, Daudén E, De la Cueva-Dobao P, Gómez-García FJ, Herrera-Ceballos E, Sánchez-Carazo JL, López-Estebaranz JL, Alsina M, Ferrán M, Torrado R, Carrascosa JM, Llamas-Velasco M, Ortiz PL, García-Doval I, Descalzo MA; Biobadaderm Study Group. Belinchón I, et al. Among authors: carrascosa jm. J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1700-1708. doi: 10.1111/jdv.14314. Epub 2017 Jun 6. J Eur Acad Dermatol Venereol. 2017. PMID: 28485816
Position statement for the management of comorbidities in psoriasis.
Dauden E, Blasco AJ, Bonanad C, Botella R, Carrascosa JM, González-Parra E, Jodar E, Joven B, Lázaro P, Olveira A, Quintero J, Rivera R. Dauden E, et al. Among authors: carrascosa jm. J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2058-2073. doi: 10.1111/jdv.15177. Epub 2018 Aug 14. J Eur Acad Dermatol Venereol. 2018. PMID: 29992631 Review.
Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective study.
Deza G, Notario J, Lopez-Ferrer A, Vilarrasa E, Ferran M, Del Alcazar E, Carrascosa JM, Corral M, Salleras M, Ribera M, Puig L, Pujol RM, Vidal D, Gallardo F. Deza G, et al. Among authors: carrascosa jm. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):553-559. doi: 10.1111/jdv.15288. Epub 2018 Nov 13. J Eur Acad Dermatol Venereol. 2019. PMID: 30317679
Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis.
de la Cueva Dobao P, Notario J, Ferrándiz C, López Estebaranz JL, Alarcón I, Sulleiro S, Borrás J, Daudén E, Carrascosa JM, Sánchez Carazo JL, Monte Boquet E, Puig L. de la Cueva Dobao P, et al. Among authors: carrascosa jm. J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1214-1223. doi: 10.1111/jdv.15600. Epub 2019 Apr 29. J Eur Acad Dermatol Venereol. 2019. PMID: 31037770
328 results